PDL1 Expression and Outcomes in Histiocytic Neoplasms
Sign Up to like & getrecommendations! Published in 2025 at "Case Reports in Oncology"
DOI: 10.1159/000546447
Abstract: Abstract Introduction: Histiocytic sarcoma (HS) and interdigitating dendritic cell sarcoma (IDCS) are both extremely rare and aggressive histiocytic neoplasms that are most often treated with lymphoma-based chemotherapy; however, there is growing use of immune checkpoint… read more here.
Keywords: expression outcomes; pdl1 expression; histiocytic neoplasms; case ... See more keywords
Association of gene expression with outcomes with everolimus as post-VEGF inhibitor therapy for renal cell carcinoma (RCC).
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e16554
Abstract: e16554Background: The use of everolimus (E) monotherapy to treat RCC has diminished due to the approvals of new agents. We hypothesized that gene expression associated with benefit may provide the ... read more here.
Keywords: association gene; rcc; expression outcomes; gene expression ... See more keywords